Mark L. Baum - Jan 20, 2022 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role
Chief Executive Officer, Director
Signature
/s/ Mark L. Baum
Stock symbol
HROW
Transactions as of
Jan 20, 2022
Transactions value $
-$294,812
Form type
4
Date filed
1/21/2022, 07:45 PM
Previous filing
Jul 23, 2021
Next filing
Dec 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HROW Common Stock Options Exercise $300K +125K +9.23% $2.40 1.48M Jan 20, 2022 Direct F1
transaction HROW Common Stock Tax liability -$595K -71.4K -4.83% $8.33 1.41M Jan 20, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HROW Stock Option (Right to buy) Options Exercise $0 -125K -100% $0.00* 0 Jan 20, 2022 Common Stock 125K $2.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock options granted to Mr. Baum on January 25, 2012 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock option vested 1/12 on a monthly basis over the one year period following the grant date. The Company withheld a total of 71,406 shares of common stock from issuance to Mr. Baum: (i) 36,014 shares withheld as consideration for the cashless exercise of the option; and (ii) an additional 35,392 shares withheld for payroll tax purposes.